2007
DOI: 10.4314/jtmb.v3i1.35450
|View full text |Cite
|
Sign up to set email alerts
|

Nasal carriage of Methicillin resistant <i>Staphylococcus aureus</i> with reduced Vancomycin susceptibility (MRSA-RVS) by healthy adults in Zaria, Nigeria

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
7
0

Year Published

2010
2010
2018
2018

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(10 citation statements)
references
References 0 publications
3
7
0
Order By: Relevance
“…This finding may be reflective of the extent of poor drug control and legislations concerning sales of antimicobials in Nigeria (Geidam et al, 2012a). This is in agreement with findings of Olonitola et al (2007) and Taiwo et al (2008) in which resistance to methicillin and other clinically important antibiotics occur rather frequently in human S. aureus isolates. Beta-lactam antibiotic resistant Staphylococci have also been suspected of being methicillin-resistant strains (Van Duijkeren et al, 2004) and may carry the mecA chromosomal gene responsible for production of the altered penicillin binding protein PBP-2a (Martineau at al., 2000).…”
Section: Discussionsupporting
confidence: 92%
“…This finding may be reflective of the extent of poor drug control and legislations concerning sales of antimicobials in Nigeria (Geidam et al, 2012a). This is in agreement with findings of Olonitola et al (2007) and Taiwo et al (2008) in which resistance to methicillin and other clinically important antibiotics occur rather frequently in human S. aureus isolates. Beta-lactam antibiotic resistant Staphylococci have also been suspected of being methicillin-resistant strains (Van Duijkeren et al, 2004) and may carry the mecA chromosomal gene responsible for production of the altered penicillin binding protein PBP-2a (Martineau at al., 2000).…”
Section: Discussionsupporting
confidence: 92%
“…This second category of antibiotics is not readily available for consumption to a majority of the populace because of its high cost. Vancomycin in particular is not available for routine clinical use in Nigeria; hence, most S. aureus isolates, including MRSA, are still susceptible to the drug,1,1215 although there are few reports of the emergence of vancomycin-intermediate and vancomycin-resistant S. aureus clinical isolates in some centers in Nigeria 28,29…”
Section: Discussionmentioning
confidence: 99%
“…The danger of such transmission to bacteria such as S. aureus and the enterobacteriaceae in our environment is apparent as some Nigerian studies have reported vancomycin resistance among clinical S. aureus isolates (Olayinka et al , 2005, Onolitola et al , 2007) without previous exposure to vancomycin. A cursory look at our study revealed that 50% and 20% of the S. aureus isolates are oxacillin and vancomycin resistant respectively.…”
Section: Discussionmentioning
confidence: 99%